{"id": "article-22800_0", "title": "Hepatocellular Adenoma -- Continuing Education Activity", "content": "Hepatocellular adenoma, also called \"hepatic adenoma,\" is a rare, benign epithelial liver tumor frequently associated with oral contraceptive pill intake.\u00a0Conditions like anabolic steroid abuse, Fanconi anemia, and aplastic anemia have also been implicated in the development of this lesion. Hepatic adenomas are benign but carry a higher hemorrhage and malignant transformation risk.", "contents": "Hepatocellular Adenoma -- Continuing Education Activity. Hepatocellular adenoma, also called \"hepatic adenoma,\" is a rare, benign epithelial liver tumor frequently associated with oral contraceptive pill intake.\u00a0Conditions like anabolic steroid abuse, Fanconi anemia, and aplastic anemia have also been implicated in the development of this lesion. Hepatic adenomas are benign but carry a higher hemorrhage and malignant transformation risk."}
{"id": "article-22800_1", "title": "Hepatocellular Adenoma -- Continuing Education Activity", "content": "Elective resection is recommended in all men with adenomas of any size and women with tumors larger than 5 cm.\u00a0Rupture may complicate\u00a0untreated lesions, manifesting with hemorrhage, severe abdominal pain, and hypotension, and may lead to hypovolemic shock and death. Women on oral contraceptives are most susceptible to liver adenoma rupture, which\u00a0requires\u00a0immediate recognition due to its potentially catastrophic consequences.", "contents": "Hepatocellular Adenoma -- Continuing Education Activity. Elective resection is recommended in all men with adenomas of any size and women with tumors larger than 5 cm.\u00a0Rupture may complicate\u00a0untreated lesions, manifesting with hemorrhage, severe abdominal pain, and hypotension, and may lead to hypovolemic shock and death. Women on oral contraceptives are most susceptible to liver adenoma rupture, which\u00a0requires\u00a0immediate recognition due to its potentially catastrophic consequences."}
{"id": "article-22800_2", "title": "Hepatocellular Adenoma -- Continuing Education Activity", "content": "This activity for healthcare professionals is designed to improve learners' competence in evaluating and managing hepatocellular adenoma. Participants gain profound insights into the condition's pathophysiology, symptomatology, and evidence-based diagnostic and treatment practices. Learners become prepared to collaborate within an interprofessional team caring for patients with or at risk for hepatic adenoma.", "contents": "Hepatocellular Adenoma -- Continuing Education Activity. This activity for healthcare professionals is designed to improve learners' competence in evaluating and managing hepatocellular adenoma. Participants gain profound insights into the condition's pathophysiology, symptomatology, and evidence-based diagnostic and treatment practices. Learners become prepared to collaborate within an interprofessional team caring for patients with or at risk for hepatic adenoma."}
{"id": "article-22800_3", "title": "Hepatocellular Adenoma -- Continuing Education Activity", "content": "Objectives: Identify the historical and physical examination features suggestive of a hepatocellular adenoma. Create a clinically guided diagnostic strategy for a person with suspected hepatic adenoma. Implement current evidence-based treatment options for an individual diagnosed with hepatocellular adenoma. Collaborate with the interprofessional team to educate, treat, and monitor\u00a0individuals with or at risk for hepatocellular adenoma. Access free multiple choice questions on this topic.", "contents": "Hepatocellular Adenoma -- Continuing Education Activity. Objectives: Identify the historical and physical examination features suggestive of a hepatocellular adenoma. Create a clinically guided diagnostic strategy for a person with suspected hepatic adenoma. Implement current evidence-based treatment options for an individual diagnosed with hepatocellular adenoma. Collaborate with the interprofessional team to educate, treat, and monitor\u00a0individuals with or at risk for hepatocellular adenoma. Access free multiple choice questions on this topic."}
{"id": "article-22800_4", "title": "Hepatocellular Adenoma -- Introduction", "content": "Hepatocellular adenoma (HCA),\u00a0otherwise known as\u00a0hepatic adenoma,\u00a0is a rare, benign epithelial hepatic neoplasm often linked to exogenous estrogen intake, usually in the form of oral contraceptive pills. The lesion\u00a0is also associated with steroid abuse, Fanconi anemia, aplastic anemia, metabolic syndrome, and glycogen storage disease (GSD). HCAs are benign but are at high risk of hemorrhage and malignant transformation. [1]", "contents": "Hepatocellular Adenoma -- Introduction. Hepatocellular adenoma (HCA),\u00a0otherwise known as\u00a0hepatic adenoma,\u00a0is a rare, benign epithelial hepatic neoplasm often linked to exogenous estrogen intake, usually in the form of oral contraceptive pills. The lesion\u00a0is also associated with steroid abuse, Fanconi anemia, aplastic anemia, metabolic syndrome, and glycogen storage disease (GSD). HCAs are benign but are at high risk of hemorrhage and malignant transformation. [1]"}
{"id": "article-22800_5", "title": "Hepatocellular Adenoma -- Introduction", "content": "Although typically solitary, multiple adenomas can occur. Hepatic adenomatosis refers to the presence of\u00a010 or more tumors.\u00a0Advances in radiologic diagnosis and subtype classifications based on molecular behavior\u00a0have emerged, which provide a more systematic approach to treating patients with hepatic adenomas. Elective resection is recommended in men with adenomas regardless of size and in women with adenomas\u00a0greater than 5 cm. [2]", "contents": "Hepatocellular Adenoma -- Introduction. Although typically solitary, multiple adenomas can occur. Hepatic adenomatosis refers to the presence of\u00a010 or more tumors.\u00a0Advances in radiologic diagnosis and subtype classifications based on molecular behavior\u00a0have emerged, which provide a more systematic approach to treating patients with hepatic adenomas. Elective resection is recommended in men with adenomas regardless of size and in women with adenomas\u00a0greater than 5 cm. [2]"}
{"id": "article-22800_6", "title": "Hepatocellular Adenoma -- Introduction -- Liver Anatomy and Histology", "content": "The liver is\u00a0located\u00a0inferior to the diaphragm and occupies the abdominal right upper quadrant (RUQ). This organ has a complex anatomical configuration crucial for its multifunctional roles. The liver is encased in the visceral peritoneum and extends from the midclavicular line to the right costal margin at the level of the 5th\u00a0intercostal space.\u00a0The organ's superoposterior aspect houses the bare area where the diaphragm and inferior vena cava (IVC) converge. [3]", "contents": "Hepatocellular Adenoma -- Introduction -- Liver Anatomy and Histology. The liver is\u00a0located\u00a0inferior to the diaphragm and occupies the abdominal right upper quadrant (RUQ). This organ has a complex anatomical configuration crucial for its multifunctional roles. The liver is encased in the visceral peritoneum and extends from the midclavicular line to the right costal margin at the level of the 5th\u00a0intercostal space.\u00a0The organ's superoposterior aspect houses the bare area where the diaphragm and inferior vena cava (IVC) converge. [3]"}
{"id": "article-22800_7", "title": "Hepatocellular Adenoma -- Introduction -- Liver Anatomy and Histology", "content": "The Couinaud classification\u00a0subdivides the liver into\u00a08 functionally independent segments based on vascularization, bile duct distribution, and lymphatic drainage. These wedge-shaped segments\u00a0have apices directed toward the hepatic hilum and receive\u00a0a single branch each of the bile duct, portal vein, and hepatic artery.", "contents": "Hepatocellular Adenoma -- Introduction -- Liver Anatomy and Histology. The Couinaud classification\u00a0subdivides the liver into\u00a08 functionally independent segments based on vascularization, bile duct distribution, and lymphatic drainage. These wedge-shaped segments\u00a0have apices directed toward the hepatic hilum and receive\u00a0a single branch each of the bile duct, portal vein, and hepatic artery."}
{"id": "article-22800_8", "title": "Hepatocellular Adenoma -- Introduction -- Liver Anatomy and Histology", "content": "Hepatic veins run between adjacent segments, ultimately draining into the IVC, while the middle hepatic vein delineates the liver's right and left lobes. The right hepatic vein further partitions the right lobe into posterior and anterior segments, while the falciform ligament separates the left lobe into medial and lateral segments. The portal vein horizontally divides segments into superior and inferior sections. Segment I\u00a0is the caudate lobe, distinguished from other lobes by its unique characteristics, such as\u00a0a dual blood supply and direct drainage into the IVC. Segments II, III, and IV constitute the left hepatic lobe sections.\u00a0Segments V, VI, VII, and VIII constitute the right lobe hepatic sections.", "contents": "Hepatocellular Adenoma -- Introduction -- Liver Anatomy and Histology. Hepatic veins run between adjacent segments, ultimately draining into the IVC, while the middle hepatic vein delineates the liver's right and left lobes. The right hepatic vein further partitions the right lobe into posterior and anterior segments, while the falciform ligament separates the left lobe into medial and lateral segments. The portal vein horizontally divides segments into superior and inferior sections. Segment I\u00a0is the caudate lobe, distinguished from other lobes by its unique characteristics, such as\u00a0a dual blood supply and direct drainage into the IVC. Segments II, III, and IV constitute the left hepatic lobe sections.\u00a0Segments V, VI, VII, and VIII constitute the right lobe hepatic sections."}
{"id": "article-22800_9", "title": "Hepatocellular Adenoma -- Introduction -- Liver Anatomy and Histology", "content": "The liver's blood supply, primarily from the portal vein, enhances liver imaging during the portal venous phase\u2014a property crucial for diagnostic purposes. Tumors supplied by the hepatic artery exhibit enhanced imaging during arterial phases, a principle utilized in therapeutic interventions like transarterial chemoembolization. Hepatic veins appear as anechoic tubes on ultrasound and drain into the IVC.\u00a0The portal triad\u2014consisting of portal veins, hepatic arteries, and bile ducts\u2014manifests as echogenic foci within the liver parenchyma. [4]", "contents": "Hepatocellular Adenoma -- Introduction -- Liver Anatomy and Histology. The liver's blood supply, primarily from the portal vein, enhances liver imaging during the portal venous phase\u2014a property crucial for diagnostic purposes. Tumors supplied by the hepatic artery exhibit enhanced imaging during arterial phases, a principle utilized in therapeutic interventions like transarterial chemoembolization. Hepatic veins appear as anechoic tubes on ultrasound and drain into the IVC.\u00a0The portal triad\u2014consisting of portal veins, hepatic arteries, and bile ducts\u2014manifests as echogenic foci within the liver parenchyma. [4]"}
{"id": "article-22800_10", "title": "Hepatocellular Adenoma -- Introduction -- Liver Anatomy and Histology", "content": "The\u00a0hepatic lobule\u00a0serves as\u00a0the primary functional unit, comprising hexagonal arrays of hepatocytes surrounding central veins. Hepatocytes organize into cords within lobules, enveloping sinusoids housing Kupffer and stellate cells. The lobule's organization into portal triads ensures efficient blood flow across zones delineated by their proximity to portal tracts or central veins. This alternative organization, known as the portal acinus, delineates functional zones. Zone 1 surrounds portal tracts involved in oxidative metabolism.\u00a0Zone 3\u00a0envelopes central veins primarily engaged in drug biotransformation.\u00a0Zone 2 exhibits mixed functionality.", "contents": "Hepatocellular Adenoma -- Introduction -- Liver Anatomy and Histology. The\u00a0hepatic lobule\u00a0serves as\u00a0the primary functional unit, comprising hexagonal arrays of hepatocytes surrounding central veins. Hepatocytes organize into cords within lobules, enveloping sinusoids housing Kupffer and stellate cells. The lobule's organization into portal triads ensures efficient blood flow across zones delineated by their proximity to portal tracts or central veins. This alternative organization, known as the portal acinus, delineates functional zones. Zone 1 surrounds portal tracts involved in oxidative metabolism.\u00a0Zone 3\u00a0envelopes central veins primarily engaged in drug biotransformation.\u00a0Zone 2 exhibits mixed functionality."}
{"id": "article-22800_11", "title": "Hepatocellular Adenoma -- Etiology", "content": "Chen and colleagues\u00a0enhanced our understanding of hepatocellular adenoma formation when their 2002 study\u00a0identified the role of \u03b2-catenin in the Wnt signaling pathway. [5] Subsequently, Bioulac-Sage and associates developed a phenotypic-genotypic classification system for hepatocellular adenomas based on molecular behavior patterns. [6] [7]  Other groups have since validated this classification scheme, which\u00a0categorizes\u00a0hepatocellular adenomas into\u00a04\u00a0main groups:", "contents": "Hepatocellular Adenoma -- Etiology. Chen and colleagues\u00a0enhanced our understanding of hepatocellular adenoma formation when their 2002 study\u00a0identified the role of \u03b2-catenin in the Wnt signaling pathway. [5] Subsequently, Bioulac-Sage and associates developed a phenotypic-genotypic classification system for hepatocellular adenomas based on molecular behavior patterns. [6] [7]  Other groups have since validated this classification scheme, which\u00a0categorizes\u00a0hepatocellular adenomas into\u00a04\u00a0main groups:"}
{"id": "article-22800_12", "title": "Hepatocellular Adenoma -- Etiology -- Hepatocyte\u00a0Nuclear\u00a0Factor\u00a0-1\u03b1 Inactivated Mutations", "content": "Patients with\u00a0hepatocyte nuclear factor-1\u03b1 (HNF-1\u03b1) inactivated mutations comprise 35% to 40% of cases. The condition involves biallelic mutations of the T-cell\u00a0factor-1 gene that encodes the transcription factor HNF-1\u03b1. This\u00a0protein\u00a0is\u00a0involved in hepatocyte differentiation, liver development,\u00a0and glucose and lipid metabolism.\u00a0HCA lesions in this group are noticeably more steatotic on biopsy. Women are mostly affected.\u00a0The mutation is likewise often associated\u00a0with mature-onset diabetes of the young (MODY3).\u00a0About 90% of the mutations are\u00a0somatic, although MODY3 association can\u00a0involve the\u00a0germline and commonly manifests with adenomatosis. Lesion size smaller than 5 cm reduces complication risk.", "contents": "Hepatocellular Adenoma -- Etiology -- Hepatocyte\u00a0Nuclear\u00a0Factor\u00a0-1\u03b1 Inactivated Mutations. Patients with\u00a0hepatocyte nuclear factor-1\u03b1 (HNF-1\u03b1) inactivated mutations comprise 35% to 40% of cases. The condition involves biallelic mutations of the T-cell\u00a0factor-1 gene that encodes the transcription factor HNF-1\u03b1. This\u00a0protein\u00a0is\u00a0involved in hepatocyte differentiation, liver development,\u00a0and glucose and lipid metabolism.\u00a0HCA lesions in this group are noticeably more steatotic on biopsy. Women are mostly affected.\u00a0The mutation is likewise often associated\u00a0with mature-onset diabetes of the young (MODY3).\u00a0About 90% of the mutations are\u00a0somatic, although MODY3 association can\u00a0involve the\u00a0germline and commonly manifests with adenomatosis. Lesion size smaller than 5 cm reduces complication risk."}
{"id": "article-22800_13", "title": "Hepatocellular Adenoma -- Etiology -- \u03b2-Catenin Activated Mutations", "content": "Individuals with\u00a0\u03b2-catenin activated mutations  constitute 15% to 20% of liver adenoma cases. The\u00a0condition is frequently\u00a0linked to androgen exposure, glycogenesis, and familial adenomatous polyposis. Mild\u00a0hepatic\u00a0cytological or architectural abnormalities lead to an acinar, pseudoglandular pattern.\u00a0The mutation\u00a0is rarely detected in\u00a0liver steatosis and inflammatory cases.\u00a0Adenomas in this\u00a0group have an increased malignant transformation risk. The lesions typically exhibit positivity for glutamine synthetase and abnormal \u03b2-catenin expression on immunohistochemical staining.", "contents": "Hepatocellular Adenoma -- Etiology -- \u03b2-Catenin Activated Mutations. Individuals with\u00a0\u03b2-catenin activated mutations  constitute 15% to 20% of liver adenoma cases. The\u00a0condition is frequently\u00a0linked to androgen exposure, glycogenesis, and familial adenomatous polyposis. Mild\u00a0hepatic\u00a0cytological or architectural abnormalities lead to an acinar, pseudoglandular pattern.\u00a0The mutation\u00a0is rarely detected in\u00a0liver steatosis and inflammatory cases.\u00a0Adenomas in this\u00a0group have an increased malignant transformation risk. The lesions typically exhibit positivity for glutamine synthetase and abnormal \u03b2-catenin expression on immunohistochemical staining."}
{"id": "article-22800_14", "title": "Hepatocellular Adenoma -- Etiology -- Inflammatory Hepatocellular Adenomas", "content": "Inflammatory HCA (IHCA) is seen in 40% to 50% of patients with HCA (see Image . Inflammatory Hepatocellular Adenoma Histopathology). Risk factors include female sex, high body mass index (BMI), excessive alcohol consumption,\u00a0and systemic inflammatory syndrome. The lesions\u00a0lack both HNF-1\u03b1 and \u03b2-catenin mutations.\u00a0IL-6 inflammatory pathway activation is implicated in IHCA development, manifesting with dystrophic\u00a0vessels and\u00a0telangiectasia. Specifically, the arteries have thick walls, and\u00a0the sinusoids are dilated, a condition called\u00a0\"peliosis.\"\u00a0Adenomas in this category were formerly called\u00a0\u201ctelangiectatic focal nodular hyperplasia.\u201d\u00a0The tumors exhibit positivity for serum amyloid A (SAA) and C-reactive protein (CRP) and demonstrate inflammatory infiltrates and ductular reactions.", "contents": "Hepatocellular Adenoma -- Etiology -- Inflammatory Hepatocellular Adenomas. Inflammatory HCA (IHCA) is seen in 40% to 50% of patients with HCA (see Image . Inflammatory Hepatocellular Adenoma Histopathology). Risk factors include female sex, high body mass index (BMI), excessive alcohol consumption,\u00a0and systemic inflammatory syndrome. The lesions\u00a0lack both HNF-1\u03b1 and \u03b2-catenin mutations.\u00a0IL-6 inflammatory pathway activation is implicated in IHCA development, manifesting with dystrophic\u00a0vessels and\u00a0telangiectasia. Specifically, the arteries have thick walls, and\u00a0the sinusoids are dilated, a condition called\u00a0\"peliosis.\"\u00a0Adenomas in this category were formerly called\u00a0\u201ctelangiectatic focal nodular hyperplasia.\u201d\u00a0The tumors exhibit positivity for serum amyloid A (SAA) and C-reactive protein (CRP) and demonstrate inflammatory infiltrates and ductular reactions."}
{"id": "article-22800_15", "title": "Hepatocellular Adenoma -- Etiology -- Unclassified Type", "content": "Patients with unclassified\u00a0HCA\u00a0comprise 10% of cases. The lesions\u00a0are negative\u00a0for CRP, SAA, \u03b2-catenin,\u00a0and glutamine synthetase\u00a0but exhibit\u00a0typical liver fatty acid-binding protein (LFABP) staining. [8] [9]", "contents": "Hepatocellular Adenoma -- Etiology -- Unclassified Type. Patients with unclassified\u00a0HCA\u00a0comprise 10% of cases. The lesions\u00a0are negative\u00a0for CRP, SAA, \u03b2-catenin,\u00a0and glutamine synthetase\u00a0but exhibit\u00a0typical liver fatty acid-binding protein (LFABP) staining. [8] [9]"}
{"id": "article-22800_16", "title": "Hepatocellular Adenoma -- Epidemiology", "content": "HCA's\u00a0annual incidence among patients taking oral contraceptive pills is 30 to 40 cases per million, compared to 1 case per million in people who do not take these medications.\u00a0A higher risk is seen after more than\u00a02 years of use. [10] A study found a 25-fold relative risk increase in women using oral contraceptive pills for over 109 months compared to those using them for less than 12 months. Discontinuation of oral contraceptives\u00a0often results in spontaneous tumor regression, supporting the link to sex hormones. HCA is more common in women than men, with a ratio of 4 to 1, although this ratio is changing due to sports-related anabolic drug use.", "contents": "Hepatocellular Adenoma -- Epidemiology. HCA's\u00a0annual incidence among patients taking oral contraceptive pills is 30 to 40 cases per million, compared to 1 case per million in people who do not take these medications.\u00a0A higher risk is seen after more than\u00a02 years of use. [10] A study found a 25-fold relative risk increase in women using oral contraceptive pills for over 109 months compared to those using them for less than 12 months. Discontinuation of oral contraceptives\u00a0often results in spontaneous tumor regression, supporting the link to sex hormones. HCA is more common in women than men, with a ratio of 4 to 1, although this ratio is changing due to sports-related anabolic drug use."}
{"id": "article-22800_17", "title": "Hepatocellular Adenoma -- Epidemiology", "content": "Other populations at risk\u00a0for developing HCA include\u00a0individuals\u00a0with\u00a0GSD\u00a0types I and III, iron-overload conditions like\u00a0\u03b2-thalassemia and hemochromatosis, and states of endogenous sex hormonal\u00a0imbalance such as Klinefelter and polycystic ovarian syndromes.\u00a0Except for polycystic ovarian syndrome, these other\u00a0conditions predominantly affect men and are often diagnosed during childhood. [11] [12]", "contents": "Hepatocellular Adenoma -- Epidemiology. Other populations at risk\u00a0for developing HCA include\u00a0individuals\u00a0with\u00a0GSD\u00a0types I and III, iron-overload conditions like\u00a0\u03b2-thalassemia and hemochromatosis, and states of endogenous sex hormonal\u00a0imbalance such as Klinefelter and polycystic ovarian syndromes.\u00a0Except for polycystic ovarian syndrome, these other\u00a0conditions predominantly affect men and are often diagnosed during childhood. [11] [12]"}
{"id": "article-22800_18", "title": "Hepatocellular Adenoma -- Pathophysiology", "content": "Genetic mutations offer new insights into the behavior of these tumors.\u00a0However, traditional knowledge highlights the strong association between sex hormones, notably oral contraceptive pills and anabolic steroids, and\u00a0HCA development. Other drugs that have been implicated include\u00a0clomiphene, recombinant human growth hormones, and barbiturates. [13]", "contents": "Hepatocellular Adenoma -- Pathophysiology. Genetic mutations offer new insights into the behavior of these tumors.\u00a0However, traditional knowledge highlights the strong association between sex hormones, notably oral contraceptive pills and anabolic steroids, and\u00a0HCA development. Other drugs that have been implicated include\u00a0clomiphene, recombinant human growth hormones, and barbiturates. [13]"}
{"id": "article-22800_19", "title": "Hepatocellular Adenoma -- Histopathology", "content": "Gross examination of HCAs reveals yellow or light brown\u00a0well-circumscribed lesions with a soft consistency. The\u00a0lesions are usually solitary, with sizes ranging from 2 to 15 cm.\u00a0HCAs tend to be larger in women on oral contraceptives.\u00a0Most are located in the right lobe and are subscapular. Microscopic\u00a0examination shows a lack of malignancy features\u00a0and\u00a0abundant glycogen or fat. Liver architecture is absent,\u00a0with central veins, bile ducts,\u00a0and portal tracts often not visualized. However,\u00a0HCAs are well-vascularized with small, thin-walled arterioles.", "contents": "Hepatocellular Adenoma -- Histopathology. Gross examination of HCAs reveals yellow or light brown\u00a0well-circumscribed lesions with a soft consistency. The\u00a0lesions are usually solitary, with sizes ranging from 2 to 15 cm.\u00a0HCAs tend to be larger in women on oral contraceptives.\u00a0Most are located in the right lobe and are subscapular. Microscopic\u00a0examination shows a lack of malignancy features\u00a0and\u00a0abundant glycogen or fat. Liver architecture is absent,\u00a0with central veins, bile ducts,\u00a0and portal tracts often not visualized. However,\u00a0HCAs are well-vascularized with small, thin-walled arterioles."}
{"id": "article-22800_20", "title": "Hepatocellular Adenoma -- Histopathology", "content": "HCAs are typically solitary tumors with monoclonal cell lines. These tumors\u00a0lack a true capsule, though\u00a0hepatocyte sheets\u00a0in the outer boundaries form their \"pseudo-capsule\" and are surrounded by otherwise normal liver tissue.\u00a0\u00a0The lack of\u00a0biliary ducts distinguishes\u00a0the lesion\u00a0from normal liver tissue (see Image . Hepatocellular Adenoma Histopathology).", "contents": "Hepatocellular Adenoma -- Histopathology. HCAs are typically solitary tumors with monoclonal cell lines. These tumors\u00a0lack a true capsule, though\u00a0hepatocyte sheets\u00a0in the outer boundaries form their \"pseudo-capsule\" and are surrounded by otherwise normal liver tissue.\u00a0\u00a0The lack of\u00a0biliary ducts distinguishes\u00a0the lesion\u00a0from normal liver tissue (see Image . Hepatocellular Adenoma Histopathology)."}
{"id": "article-22800_21", "title": "Hepatocellular Adenoma -- History and Physical -- History", "content": "About half of patients with\u00a0HCAs are asymptomatic,\u00a0with the tumor\u00a0discovered incidentally on imaging. The condition presents variably in symptomatic individuals, ranging from\u00a0mild, ill-defined\u00a0epigastric pain\u00a0with bloating to severe, acute RUQ pain. [14] Adenoma rupture may be accompanied by dizziness, intractable vomiting, and lethargy. [15] The pain may radiate to the right flank in some cases, resembling cholecystitis or a urinary tract pathology.\u00a0Rupture occurs in up\u00a0to 27% of HCAs,\u00a0resulting in\u00a0a\u00a05% to 10%\u00a0mortality rate. [16]", "contents": "Hepatocellular Adenoma -- History and Physical -- History. About half of patients with\u00a0HCAs are asymptomatic,\u00a0with the tumor\u00a0discovered incidentally on imaging. The condition presents variably in symptomatic individuals, ranging from\u00a0mild, ill-defined\u00a0epigastric pain\u00a0with bloating to severe, acute RUQ pain. [14] Adenoma rupture may be accompanied by dizziness, intractable vomiting, and lethargy. [15] The pain may radiate to the right flank in some cases, resembling cholecystitis or a urinary tract pathology.\u00a0Rupture occurs in up\u00a0to 27% of HCAs,\u00a0resulting in\u00a0a\u00a05% to 10%\u00a0mortality rate. [16]"}
{"id": "article-22800_22", "title": "Hepatocellular Adenoma -- History and Physical -- History", "content": "Individuals with suspected HCA should be asked about the symptoms, especially abdominal pain and its characteristics. Risk factors must be assessed, including prolonged sex hormone use and underlying conditions like GSD and obesity. The family history may reveal liver diseases or malignancies and other genetic conditions predisposing to HCA evolution.", "contents": "Hepatocellular Adenoma -- History and Physical -- History. Individuals with suspected HCA should be asked about the symptoms, especially abdominal pain and its characteristics. Risk factors must be assessed, including prolonged sex hormone use and underlying conditions like GSD and obesity. The family history may reveal liver diseases or malignancies and other genetic conditions predisposing to HCA evolution."}
{"id": "article-22800_23", "title": "Hepatocellular Adenoma -- History and Physical -- Physical Examination", "content": "A complete physical examination helps determine the diagnosis and the patient's hemodynamic status. Individuals with abdominal pain due to gastrointestinal pathology often lie still, in contrast to patients with renal colic. Tachycardia and hypotension are possible indicators of shock. Fever may manifest due to inflammation and is a physical feature shared with many other conditions, including hepatitis.", "contents": "Hepatocellular Adenoma -- History and Physical -- Physical Examination. A complete physical examination helps determine the diagnosis and the patient's hemodynamic status. Individuals with abdominal pain due to gastrointestinal pathology often lie still, in contrast to patients with renal colic. Tachycardia and hypotension are possible indicators of shock. Fever may manifest due to inflammation and is a physical feature shared with many other conditions, including hepatitis."}
{"id": "article-22800_24", "title": "Hepatocellular Adenoma -- History and Physical -- Physical Examination", "content": "Some patients may have dry oral mucosa and poor skin turgor from dehydration. Pallor and poor pulses may\u00a0be appreciated\u00a0due to hemorrhage. Normal chest auscultation findings may rule out a cardiac\u00a0or\u00a0pulmonary cause of referred abdominal pain unless such illnesses coexist.\u00a0The abdominal examination may reveal hepatomegaly with tenderness. Abdominal rigidity may be a sign of peritoneal irritation from hemoperitoneum\u00a0due to\u00a0tumor\u00a0rupture.", "contents": "Hepatocellular Adenoma -- History and Physical -- Physical Examination. Some patients may have dry oral mucosa and poor skin turgor from dehydration. Pallor and poor pulses may\u00a0be appreciated\u00a0due to hemorrhage. Normal chest auscultation findings may rule out a cardiac\u00a0or\u00a0pulmonary cause of referred abdominal pain unless such illnesses coexist.\u00a0The abdominal examination may reveal hepatomegaly with tenderness. Abdominal rigidity may be a sign of peritoneal irritation from hemoperitoneum\u00a0due to\u00a0tumor\u00a0rupture."}
{"id": "article-22800_25", "title": "Hepatocellular Adenoma -- Evaluation", "content": "Laboratory tests are generally unhelpful in diagnosing hepatocellular adenomas, though they can help rule out other disorders and\u00a0determine hematologic and metabolic status. \u03b1-fetoprotein (AFP) levels are typically normal but can rise if malignant transformation to hepatocellular carcinoma (HCC) occurs. Hepatitis tests should be conducted to rule out these infections. Alkaline phosphatase and \u03b3-glutamyl transferase levels may increase two- to threefold, especially in IHCAs. White blood cell\u00a0count, fibrinogen, and CRP may also be elevated. [17] [18] [19]", "contents": "Hepatocellular Adenoma -- Evaluation. Laboratory tests are generally unhelpful in diagnosing hepatocellular adenomas, though they can help rule out other disorders and\u00a0determine hematologic and metabolic status. \u03b1-fetoprotein (AFP) levels are typically normal but can rise if malignant transformation to hepatocellular carcinoma (HCC) occurs. Hepatitis tests should be conducted to rule out these infections. Alkaline phosphatase and \u03b3-glutamyl transferase levels may increase two- to threefold, especially in IHCAs. White blood cell\u00a0count, fibrinogen, and CRP may also be elevated. [17] [18] [19]"}
{"id": "article-22800_26", "title": "Hepatocellular Adenoma -- Evaluation", "content": "Core needle biopsy has limited diagnostic value in HCA.\u00a0However,\u00a0immunohistochemical markers\u00a0may\u00a0be helpful\u00a0in expert centers. Biopsy should be limited to rare cases where imaging is equivocal, and the diagnosis\u00a0may\u00a0alter management strategy.", "contents": "Hepatocellular Adenoma -- Evaluation. Core needle biopsy has limited diagnostic value in HCA.\u00a0However,\u00a0immunohistochemical markers\u00a0may\u00a0be helpful\u00a0in expert centers. Biopsy should be limited to rare cases where imaging is equivocal, and the diagnosis\u00a0may\u00a0alter management strategy."}
{"id": "article-22800_27", "title": "Hepatocellular Adenoma -- Evaluation", "content": "Ultrasonography often fails to distinguish between benign and malignant tumors. Doppler ultrasonography may demonstrate arterial hypervascularity with vessels running along the lesion's border in a \"basket\" pattern. Some\u00a0tumors\u00a0may appear hyperechoic due to the hepatocytes' steatotic content.", "contents": "Hepatocellular Adenoma -- Evaluation. Ultrasonography often fails to distinguish between benign and malignant tumors. Doppler ultrasonography may demonstrate arterial hypervascularity with vessels running along the lesion's border in a \"basket\" pattern. Some\u00a0tumors\u00a0may appear hyperechoic due to the hepatocytes' steatotic content."}
{"id": "article-22800_28", "title": "Hepatocellular Adenoma -- Evaluation", "content": "Dynamic magnetic resonance imaging (MRI) with a hepatocyte-specific contrast agent\u00a0like gadobenate\u00a0dimeglumine is the modality of choice for diagnosing HCAs. This method\u00a0can distinguish between hepatocellular adenomas and other benign and malignant liver tumors (see Image . Hepatocellular Adenoma on Magnetic Resonance Imaging). The\u00a0lesion may exhibit a clearly\u00a0defined central margin with nearly parallel vessels entering from the periphery, giving the appearance of a spoked wheel.\u00a0In some cases, dynamic MRI\u00a0may demonstrate a tortuosity of peripheral vessels with central necrosis.", "contents": "Hepatocellular Adenoma -- Evaluation. Dynamic magnetic resonance imaging (MRI) with a hepatocyte-specific contrast agent\u00a0like gadobenate\u00a0dimeglumine is the modality of choice for diagnosing HCAs. This method\u00a0can distinguish between hepatocellular adenomas and other benign and malignant liver tumors (see Image . Hepatocellular Adenoma on Magnetic Resonance Imaging). The\u00a0lesion may exhibit a clearly\u00a0defined central margin with nearly parallel vessels entering from the periphery, giving the appearance of a spoked wheel.\u00a0In some cases, dynamic MRI\u00a0may demonstrate a tortuosity of peripheral vessels with central necrosis."}
{"id": "article-22800_29", "title": "Hepatocellular Adenoma -- Evaluation", "content": "A dynamic computed tomography (CT) scan is also potentially useful in evaluating HCAs. Dynamic CT may show\u00a0peripheral enhancement of the tumors\u00a0during the early phase, transitioning to centripetal flow in the later portal venous phase.", "contents": "Hepatocellular Adenoma -- Evaluation. A dynamic computed tomography (CT) scan is also potentially useful in evaluating HCAs. Dynamic CT may show\u00a0peripheral enhancement of the tumors\u00a0during the early phase, transitioning to centripetal flow in the later portal venous phase."}
{"id": "article-22800_30", "title": "Hepatocellular Adenoma -- Treatment / Management", "content": "HCAs less than 5 cm in size and linked to oral contraceptive pills are initially approached conservatively. Oral contraceptive withdrawal\u00a0with\u00a0regular imaging surveillance has demonstrated significant tumor regression in numerous cases. Resuming oral contraceptive\u00a0intake\u00a0requires careful radiologic monitoring. The optimal follow-up duration remains unestablished, with some authors suggesting surveillance until menopause. Refractory tumors often correlate with obesity.", "contents": "Hepatocellular Adenoma -- Treatment / Management. HCAs less than 5 cm in size and linked to oral contraceptive pills are initially approached conservatively. Oral contraceptive withdrawal\u00a0with\u00a0regular imaging surveillance has demonstrated significant tumor regression in numerous cases. Resuming oral contraceptive\u00a0intake\u00a0requires careful radiologic monitoring. The optimal follow-up duration remains unestablished, with some authors suggesting surveillance until menopause. Refractory tumors often correlate with obesity."}
{"id": "article-22800_31", "title": "Hepatocellular Adenoma -- Treatment / Management", "content": "Most\u00a0hepatic adenomas remain stable during pregnancy.\u00a0Tertiary centers often monitor adenomas\u00a0smaller\u00a0than 5 cm serially in pregnant women every\u00a03\u00a0months and during the postpartum period.\u00a0Patients with small adenomas are not discouraged from getting pregnant.", "contents": "Hepatocellular Adenoma -- Treatment / Management. Most\u00a0hepatic adenomas remain stable during pregnancy.\u00a0Tertiary centers often monitor adenomas\u00a0smaller\u00a0than 5 cm serially in pregnant women every\u00a03\u00a0months and during the postpartum period.\u00a0Patients with small adenomas are not discouraged from getting pregnant."}
{"id": "article-22800_32", "title": "Hepatocellular Adenoma -- Treatment / Management", "content": "Surgical resection is recommended for all male patients regardless of the tumor size and for women with tumors larger than 5 cm. The technique does not require a wide margin or regional lymphadenectomy. Emergent surgery for a ruptured hepatic adenoma with intraperitoneal bleeding has a mortality rate of 5% to 10%. In contrast, elective resection's mortality rate is\u00a0less than 1%.", "contents": "Hepatocellular Adenoma -- Treatment / Management. Surgical resection is recommended for all male patients regardless of the tumor size and for women with tumors larger than 5 cm. The technique does not require a wide margin or regional lymphadenectomy. Emergent surgery for a ruptured hepatic adenoma with intraperitoneal bleeding has a mortality rate of 5% to 10%. In contrast, elective resection's mortality rate is\u00a0less than 1%."}
{"id": "article-22800_33", "title": "Hepatocellular Adenoma -- Treatment / Management", "content": "Transarterial embolization (TAE) is recommended for hepatic adenomas complicated by hemorrhage. Patients with intratumoral hemorrhage rarely present with hemodynamic instability. In such cases, TAE may be followed by elective surgical resection of the adenoma. TAE is indicated within 2 to 3 days of tumoral hemorrhage.", "contents": "Hepatocellular Adenoma -- Treatment / Management. Transarterial embolization (TAE) is recommended for hepatic adenomas complicated by hemorrhage. Patients with intratumoral hemorrhage rarely present with hemodynamic instability. In such cases, TAE may be followed by elective surgical resection of the adenoma. TAE is indicated within 2 to 3 days of tumoral hemorrhage."}
{"id": "article-22800_34", "title": "Hepatocellular Adenoma -- Treatment / Management", "content": "Radiofrequency ablation is appropriate only for a very select patient population.\u00a0The modality is not appropriate for\u00a0surgical candidates and individuals with hormone-sensitive tumors, underlying liver disease, or a desire for pregnancy. Radiofrequency ablation should be used to treat patients with adenomas less than 4 cm in size.", "contents": "Hepatocellular Adenoma -- Treatment / Management. Radiofrequency ablation is appropriate only for a very select patient population.\u00a0The modality is not appropriate for\u00a0surgical candidates and individuals with hormone-sensitive tumors, underlying liver disease, or a desire for pregnancy. Radiofrequency ablation should be used to treat patients with adenomas less than 4 cm in size."}
{"id": "article-22800_35", "title": "Hepatocellular Adenoma -- Treatment / Management", "content": "Obesity, nonalcoholic steatohepatitis, and metabolic syndromes increase the risk of developing hepatic adenomatosis.\u00a0Complications\u00a0like\u00a0hemorrhage or malignant transformation\u00a0correlate\u00a0less\u00a0with\u00a0adenomatosis\u00a0than the tumors'\u00a0molecular signatures. Moreover, most liver adenomatoses are typically associated with HNF-1\u03b1 mutations, which have a low risk for malignant transformations.\u00a0Thus, a liver transplant is generally not indicated for nonresectable hepatic adenomas. Exceptions involve men with intrahepatic portosystemic venous shunts with nonresectable hepatic adenomas.\u00a0Genetic counseling is recommended for patients with liver adenomatosis,\u00a0especially if\u00a0associated with familial adenomatous polyposis or MODY3.", "contents": "Hepatocellular Adenoma -- Treatment / Management. Obesity, nonalcoholic steatohepatitis, and metabolic syndromes increase the risk of developing hepatic adenomatosis.\u00a0Complications\u00a0like\u00a0hemorrhage or malignant transformation\u00a0correlate\u00a0less\u00a0with\u00a0adenomatosis\u00a0than the tumors'\u00a0molecular signatures. Moreover, most liver adenomatoses are typically associated with HNF-1\u03b1 mutations, which have a low risk for malignant transformations.\u00a0Thus, a liver transplant is generally not indicated for nonresectable hepatic adenomas. Exceptions involve men with intrahepatic portosystemic venous shunts with nonresectable hepatic adenomas.\u00a0Genetic counseling is recommended for patients with liver adenomatosis,\u00a0especially if\u00a0associated with familial adenomatous polyposis or MODY3."}
{"id": "article-22800_36", "title": "Hepatocellular Adenoma -- Treatment / Management", "content": "About 4% to 5% of hepatic adenomas are at risk for malignant transformation to HCC, with the risk increased by Fanconi anemia and\u00a0androgen treatments. The Wnt and\u00a0\u03b2-catenin pathways are particularly associated with malignant transformation.\u00a0Surgical resection\u00a0is\u00a0typically recommended for this subtype. [20]", "contents": "Hepatocellular Adenoma -- Treatment / Management. About 4% to 5% of hepatic adenomas are at risk for malignant transformation to HCC, with the risk increased by Fanconi anemia and\u00a0androgen treatments. The Wnt and\u00a0\u03b2-catenin pathways are particularly associated with malignant transformation.\u00a0Surgical resection\u00a0is\u00a0typically recommended for this subtype. [20]"}
{"id": "article-22800_37", "title": "Hepatocellular Adenoma -- Differential Diagnosis", "content": "The differential diagnosis of liver lesions suspicious for HCA includes hemangioma, focal nodular hyperplasia (FNH), HCC, and metastatic tumors. Dynamic contrast-enhanced\u00a0MRI can differentiate between HCA and hemangiomas, which\u00a0generally exhibit peripheral enhancement and a centripetal fill-in pattern. [21] Gadolinium-based contrast MRI\u00a0often shows FNH\u00a0taking up more contrast in the hepatobiliary phase than HCA, along with a central scar and lobulated appearance. [22]", "contents": "Hepatocellular Adenoma -- Differential Diagnosis. The differential diagnosis of liver lesions suspicious for HCA includes hemangioma, focal nodular hyperplasia (FNH), HCC, and metastatic tumors. Dynamic contrast-enhanced\u00a0MRI can differentiate between HCA and hemangiomas, which\u00a0generally exhibit peripheral enhancement and a centripetal fill-in pattern. [21] Gadolinium-based contrast MRI\u00a0often shows FNH\u00a0taking up more contrast in the hepatobiliary phase than HCA, along with a central scar and lobulated appearance. [22]"}
{"id": "article-22800_38", "title": "Hepatocellular Adenoma -- Differential Diagnosis", "content": "The clinical scenario is crucial in distinguishing between HCA and\u00a0HCC or metastatic disease.\u00a0Individuals with HCC typically have underlying chronic liver disease with or without cirrhosis.\u00a0People with metastatic disease typically have a known extrahepatic primary malignancy and associated risk factors.", "contents": "Hepatocellular Adenoma -- Differential Diagnosis. The clinical scenario is crucial in distinguishing between HCA and\u00a0HCC or metastatic disease.\u00a0Individuals with HCC typically have underlying chronic liver disease with or without cirrhosis.\u00a0People with metastatic disease typically have a known extrahepatic primary malignancy and associated risk factors."}
{"id": "article-22800_39", "title": "Hepatocellular Adenoma -- Prognosis", "content": "The prognosis for patients with\u00a0hepatocellular adenoma\u00a0remains poorly established. Oral contraceptive discontinuation may result in the regression or resolution of some lesions. As previously stated, about 27% of HCAs may rupture, which has a 5% to 10% mortality risk. The risk of HCA's malignant transformation is 4.2%. [23] The risk of malignancy generally persists even after discontinuing oral contraceptives.", "contents": "Hepatocellular Adenoma -- Prognosis. The prognosis for patients with\u00a0hepatocellular adenoma\u00a0remains poorly established. Oral contraceptive discontinuation may result in the regression or resolution of some lesions. As previously stated, about 27% of HCAs may rupture, which has a 5% to 10% mortality risk. The risk of HCA's malignant transformation is 4.2%. [23] The risk of malignancy generally persists even after discontinuing oral contraceptives."}
{"id": "article-22800_40", "title": "Hepatocellular Adenoma -- Prognosis", "content": "Complete HCA resolution is\u00a0unlikely\u00a0in most patients. About 25% of women will continue to have\u00a0RUQ pain,\u00a0with hemorrhage potentially occurring in up to 30% to 45% of women.\u00a0Bleeding\u00a0may\u00a0occur within the lesion or peritoneum. The larger the lesion, the higher the risk of hemorrhage. Pregnancy has been associated with HCA\u00a0enlargement and increased rupture risk.", "contents": "Hepatocellular Adenoma -- Prognosis. Complete HCA resolution is\u00a0unlikely\u00a0in most patients. About 25% of women will continue to have\u00a0RUQ pain,\u00a0with hemorrhage potentially occurring in up to 30% to 45% of women.\u00a0Bleeding\u00a0may\u00a0occur within the lesion or peritoneum. The larger the lesion, the higher the risk of hemorrhage. Pregnancy has been associated with HCA\u00a0enlargement and increased rupture risk."}
{"id": "article-22800_41", "title": "Hepatocellular Adenoma -- Complications", "content": "HCA's complications include tumor rupture and hemorrhage, which\u00a0may result in hemorrhagic shock and death. Tumors\u00a0larger than 5 cm have an increased rupture risk. The malignant transformation of HCAs is greater in men than women with tumors larger than 5 cm.", "contents": "Hepatocellular Adenoma -- Complications. HCA's complications include tumor rupture and hemorrhage, which\u00a0may result in hemorrhagic shock and death. Tumors\u00a0larger than 5 cm have an increased rupture risk. The malignant transformation of HCAs is greater in men than women with tumors larger than 5 cm."}
{"id": "article-22800_42", "title": "Hepatocellular Adenoma -- Consultations", "content": "HCA management requires interprofessional care coordination involving gastroenterologists, radiologists, and surgeons. The interprofessional approach\u00a0enhances diagnostic accuracy\u00a0and therapeutic or surveillance efficacy.", "contents": "Hepatocellular Adenoma -- Consultations. HCA management requires interprofessional care coordination involving gastroenterologists, radiologists, and surgeons. The interprofessional approach\u00a0enhances diagnostic accuracy\u00a0and therapeutic or surveillance efficacy."}
{"id": "article-22800_43", "title": "Hepatocellular Adenoma -- Deterrence and Patient Education", "content": "Primary prevention of HCAs involves minimizing exposure to known risk factors, such as oral contraceptives and anabolic steroids. Education about the risks associated with these medications and their potential to induce HCA development is crucial.\u00a0Making healthy lifestyle choices, including weight management and\u00a0avoiding excessive alcohol consumption, may also help decrease the risk of developing HCAs.", "contents": "Hepatocellular Adenoma -- Deterrence and Patient Education. Primary prevention of HCAs involves minimizing exposure to known risk factors, such as oral contraceptives and anabolic steroids. Education about the risks associated with these medications and their potential to induce HCA development is crucial.\u00a0Making healthy lifestyle choices, including weight management and\u00a0avoiding excessive alcohol consumption, may also help decrease the risk of developing HCAs."}
{"id": "article-22800_44", "title": "Hepatocellular Adenoma -- Deterrence and Patient Education", "content": "Meanwhile, patients with the condition or genetic risks for its development must be counseled about potential complications, eg, rupture and HCC, and their likelihood if no treatment is taken. Female patients should be advised that pregnancy is not contraindicated, especially with lesions of 5 cm or less.\u00a0However, pregnant patients with HCA must receive interprofessional care and meticulous tumor monitoring. If surgery is warranted during pregnancy, resections should ideally occur during the 2nd trimester when risks to both mother and fetus are at their lowest. Patients must be fully informed of their condition and any action's options, risks, and benefits.", "contents": "Hepatocellular Adenoma -- Deterrence and Patient Education. Meanwhile, patients with the condition or genetic risks for its development must be counseled about potential complications, eg, rupture and HCC, and their likelihood if no treatment is taken. Female patients should be advised that pregnancy is not contraindicated, especially with lesions of 5 cm or less.\u00a0However, pregnant patients with HCA must receive interprofessional care and meticulous tumor monitoring. If surgery is warranted during pregnancy, resections should ideally occur during the 2nd trimester when risks to both mother and fetus are at their lowest. Patients must be fully informed of their condition and any action's options, risks, and benefits."}
{"id": "article-22800_45", "title": "Hepatocellular Adenoma -- Pearls and Other Issues", "content": "HCAs are rare liver tumors often linked to oral contraceptive intake in reproductive-age women. Obesity,\u00a0metabolic dysfunction associated with steatohepatitis,\u00a0and metabolic syndromes are associated with hepatocellular adenomatosis. The most dreaded complications of this condition include rupture and HCC.", "contents": "Hepatocellular Adenoma -- Pearls and Other Issues. HCAs are rare liver tumors often linked to oral contraceptive intake in reproductive-age women. Obesity,\u00a0metabolic dysfunction associated with steatohepatitis,\u00a0and metabolic syndromes are associated with hepatocellular adenomatosis. The most dreaded complications of this condition include rupture and HCC."}
{"id": "article-22800_46", "title": "Hepatocellular Adenoma -- Pearls and Other Issues", "content": "The phenotypic-genotypic classification system for\u00a0this condition is validated and valuable in understanding molecular behavior patterns. The HNF-1\u03b1 subtype, associated with hepatocyte differentiation, is prevalent in women and individuals with MODY3. \u03b2-catenin-activated mutations, found in 15% to 20% of HCAs, are often linked to male hormone exposure\u00a0and carry a greater risk of malignant transformation.\u00a0Surgical resection is recommended for this subtype. IHCAs, prevalent in women with higher BMI and alcohol intake, stain positively for\u00a0SAA and CRP. Unclassified types lack the features exhibited by other types and comprise 10% of HCA cases.", "contents": "Hepatocellular Adenoma -- Pearls and Other Issues. The phenotypic-genotypic classification system for\u00a0this condition is validated and valuable in understanding molecular behavior patterns. The HNF-1\u03b1 subtype, associated with hepatocyte differentiation, is prevalent in women and individuals with MODY3. \u03b2-catenin-activated mutations, found in 15% to 20% of HCAs, are often linked to male hormone exposure\u00a0and carry a greater risk of malignant transformation.\u00a0Surgical resection is recommended for this subtype. IHCAs, prevalent in women with higher BMI and alcohol intake, stain positively for\u00a0SAA and CRP. Unclassified types lack the features exhibited by other types and comprise 10% of HCA cases."}
{"id": "article-22800_47", "title": "Hepatocellular Adenoma -- Pearls and Other Issues", "content": "Laboratory diagnosis is often unhelpful diagnostically. However, MRI can help reliably distinguish HCAs from other liver conditions. Imaging complements clinical examination during the diagnostic process.\u00a0Discontinuation of oral contraceptives can induce regression in adenomas less than 5 cm, warranting continued imaging surveillance. Surgery is generally recommended for tumors greater than 5 cm in size but does not require wide margins or regional lymphadenectomy.", "contents": "Hepatocellular Adenoma -- Pearls and Other Issues. Laboratory diagnosis is often unhelpful diagnostically. However, MRI can help reliably distinguish HCAs from other liver conditions. Imaging complements clinical examination during the diagnostic process.\u00a0Discontinuation of oral contraceptives can induce regression in adenomas less than 5 cm, warranting continued imaging surveillance. Surgery is generally recommended for tumors greater than 5 cm in size but does not require wide margins or regional lymphadenectomy."}
{"id": "article-22800_48", "title": "Hepatocellular Adenoma -- Enhancing Healthcare Team Outcomes", "content": "Prevention rather than treatment is the main focus of HCA management. Patient education involves the primary care physician, pharmacist, and nurse, contributing to better outcomes through interprofessional management. Once detected, the gastroenterologist and surgeon's roles\u2014primarily surveillance and possibly treatment\u2014become invaluable in minimizing morbidity and mortality. Pregnant women must be under the care of a high-risk obstetric care specialist, who may coordinate with the interprofessional team.", "contents": "Hepatocellular Adenoma -- Enhancing Healthcare Team Outcomes. Prevention rather than treatment is the main focus of HCA management. Patient education involves the primary care physician, pharmacist, and nurse, contributing to better outcomes through interprofessional management. Once detected, the gastroenterologist and surgeon's roles\u2014primarily surveillance and possibly treatment\u2014become invaluable in minimizing morbidity and mortality. Pregnant women must be under the care of a high-risk obstetric care specialist, who may coordinate with the interprofessional team."}
{"id": "article-22800_49", "title": "Hepatocellular Adenoma -- Enhancing Healthcare Team Outcomes", "content": "All women prescribed oral contraceptives should be warned about the risk of developing this lesion, with lower doses potentially reducing the risk. Patients without other contraception options should be educated on\u00a0HCA symptoms and when to seek help. Pregnancy increases HCA's hemorrhage risk and maternal mortality. Women with large or symptomatic tumors who desire pregnancy should be counseled about considering HCA removal before conceiving. Ongoing imaging surveillance, possibly annually, is recommended, especially for lesions larger than 5 cm. [24] [25]", "contents": "Hepatocellular Adenoma -- Enhancing Healthcare Team Outcomes. All women prescribed oral contraceptives should be warned about the risk of developing this lesion, with lower doses potentially reducing the risk. Patients without other contraception options should be educated on\u00a0HCA symptoms and when to seek help. Pregnancy increases HCA's hemorrhage risk and maternal mortality. Women with large or symptomatic tumors who desire pregnancy should be counseled about considering HCA removal before conceiving. Ongoing imaging surveillance, possibly annually, is recommended, especially for lesions larger than 5 cm. [24] [25]"}
{"id": "article-22800_50", "title": "Hepatocellular Adenoma -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Hepatocellular Adenoma -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}